BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/8/2025 9:28:54 AM | Browse: 17 | Download: 0
Publication Name World Journal of Orthopedics
Manuscript ID 114984
Country China
Category Orthopedics
Manuscript Type Case Control Study
Article Title Risk factors for thoracic-osteoporotic thoracic vertebral compression fractures during the normalized prevention and control period of COVID-19
Manuscript Source Unsolicited Manuscript
All Author List Yi-Fan Li, Chen-Qiong Wu, Yang Long, Qi-Feng Yu, Wei Xu, Jian-Jie Zhao, Xiang-Yang Zhang and Zhi-Kun Li
Funding Agency and Grant Number
Funding Agency Grant Number
Shanghai Municipal Health Commission 2022YQ006
Doctoral Innovation Base Project in Changning District RCJD2022S02
Corresponding Author Zhi-Kun Li, MD, PhD, Department of Spine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111 Xianxia Road, Shanghai 200080, China. lizhikun@shsmu.edu.cn
Key Words COVID-19; Normalized prevention and control; Osteoporotic vertebral compression fracture; Risk factor; Cough
Core Tip During the normalized prevention and control period of coronavirus disease 2019, compared with cases in the same period, cough is the main cause of osteoporotic vertebral compression fracture (OVCF), and most fractures are thoracic fractures. After percutaneous vertebroplasty treatment, the improvement of pain and function in patients is not significantly different from that in the same period. Regression analysis shows that cause of fracture, nucleic acid test result, body mass index, and bone mineral density are independent risk factors for thoracic OVCF. For elderly COVID-19-positive patients with recurrent cough, timely and active treatment of lung diseases, aggressive anti-osteoporosis therapy, and wearing a thoracic brace for protection are effective measures to prevent thoracic OVCF.
Citation Li YF, Wu CQ, Long Y, Yu QF, Xu W, Zhao JJ, Zhang XY, Li ZK. Risk factors for thoracic-osteoporotic thoracic vertebral compression fractures during the normalized prevention and control period of COVID-19. World J Orthop 2025; In press
Received
2025-10-11 08:54
Peer-Review Started
2025-10-11 08:54
First Decision by Editorial Office Director
2025-10-23 08:24
Return for Revision
2025-10-23 08:24
Revised
2025-10-30 14:49
Publication Fee Transferred
2025-11-01 13:37
Second Decision by Editor
2025-12-08 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-08 09:28
Articles in Press
2025-12-08 09:28
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2218-5836 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com